Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 3Leiomyoma 2cyclopia sequence 1Vomiting 1Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Pain 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Nausea 1Myasthenia Gravis 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Lung Neoplasms 1Lower Urinary Tract Symptoms 1Insulin Resistance 1Infertility 1Hyperandrogenism 1Hot Flashes 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Diarrhea 1Carcinoma, Non-Small-Cell Lung 1

Interventions

telapristone acetate 9vilaprisan 6ulipristal acetate 4Sugars 2Mifepristone 2Bupivacaine 2ulipristal 1ferrous sulfate 1epigallocatechin gallate 1Vitamin B 6 1Uterine Myomectomy 1Tranexamic Acid 1Tea 1Standard of Care 1Radiofrequency Ablation 1Pregabalin 1Morphine 1Misoprostol 1Lidocaine 1Leuprolide 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Leiomyoma × Sugars × Clear all
NCT00735553 2014-08-21

Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids

Repros Therapeutics Inc.

Phase 3 Terminated
77 enrolled 1 chart

Leiomyoma

NCT00785356 2014-08-21

Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

Repros Therapeutics Inc.

Phase 3 Terminated
8 enrolled 1 chart
Classical hematology

Anemia, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡